HOME |
Trial Report: 20bThis report covers the period Thursday 25 May - Thursday 1 June, 2000. Thursday 25 May 2000 The court moved to Speskop, headquarters of the South African Defence Force's Special Forces during the 1980s and early 1990s - and home of the Civil Cooperation Bureau - for an inspection in loco. Back in court Dr. Schalk Van Rensburg continued his testimony. Van Rensburg met Basson in 1983 during a visit by Basson to the Medical Research Council, where Van Rensburg worked, to discuss the problems of biological warfare. On August 1, 1984, Van Rensburg joined Roodeplaat Research Laboratories, where he thought he would be engaged in research on various micro-toxins being used as weapons by Russian and Cuban troops in Angola. At that stage, Van Rensburg believed there was a very real threat of chemical warfare being used against South African security forces, and despite the fact that he never supported apartheid, had no reservations about working for a military laboratory dedicated to the protection of South African troops and development of countermeasures to the dirty tricks being used against them. Van Rensburg said that Basson was the undisputed external director of research, who identified priorities and supplied guidelines for research. Van Rensburg himself was actively involved in only one project, as adviser to the team working on an anti-fertility vaccine. The idea for this came from Basson. He told the court there was no or little defensive work done by RRL, with the exception of projects designed specifically to protect RRL's own employees or agents handling bio-weapons in the field. According to Van Rensburg, Basson's highest priority was the search for a substance that would kill in a way that made death appear from natural causes and would not be readily detectable during post-mortem forensic tests. Both Basson and Swanepoel repeatedly urged RRL scientists to find such a substance. During cross examination, Van Rensburg was challenged on his claim that RRL conducted only offensive biological work and that defensive work was "done elsewhere". In response, Van Rensburg quoted a breakdown of the work done for the Defence Force. Of the products delivered by RRL to the SADF, 36% were lethal toxins, 36% were applicators, 18% were pathogens "that could cause severe illness", 10% were irritants and 3% were psychogenic agents. Within weeks of joining RRL in mid-1984 it had dawned on Van Rensburg that RRL was an offensive plant, he said, and throughout his tenure, only about 6% of all RRL projects were not offensive. The court adjourned until 29 May. Monday 29 May 2000 Former director of research at Roodeplaat, Dr Andre Immelman began his testimony. Immelman served for 10 years on the Veterinary Control Council and joined RRL in January 1984, having been recruited by a former student, Dr James Davies. Immelman said RRL had "outstanding" animal facilities and in this and other respects, was not only the leading laboratory in South Africa, but compared favourably with numerous international facilities. Immelman said he was responsible for the planning of the Compression Laboratory at RRL and had planned it with products like Sarin, Tabun and VX in mind. Immelman testified that he initially believed the Defence Force project was entirely defensive, in response to a CBW threat identified by the military. Immelman knew Basson as the SADF contact man and expert, who supplied RRL with guidelines for research. CBW was a virgin field of research for the RRL scientists and they were almost totally dependent on Basson to identify projects. Immelman and Basson met regularly, Basson being a frequent visitor to RRL. Immelman and Basson continually discussed projects, and Basson could veto any project if he did not believe it to be in the SADF's interest, or request research on a specific substance or application options. Projects at RRL consisted of identifying toxins and establishing how they worked, whether or not they could be traced through forensic examination, what their stability was when added to food and various drinks and which routes were suitable for application - oral, inhalation, skin, intramuscular or intravenous. Lists of "hard" or SADF projects were filed with the court. The 1985 list of 10 projects includes toxicity of paraoxon in baboons and ionophore antibiotics. (EXHIBIT 63 R) The 1986 list contains 40 projects, including paraoxon synthesis, toxicity tests for Brodifacum, data bases for organophosphates and psychotropic substances and evaluation of the anti-fertility potential of various substances. (EXHIBIT 63 S) At some point, H projects became R projects and EXHIBIT 63 T lists 197 of them. Immelman said there were "cases and cases" of pathogens in the microbiology laboratory, where in addition to "hard" projects, research was also done into antibiotics on behalf of pharmaceutical companies. Both bacteria and yeast cultures were present. According to the witness, the synthesis of paraoxon was an ongoing project and there was always "plenty" available. EXHIBIT 63 U (1) outlines the most effective use of paraoxon, one of RRL's earliest projects. Immelman explained that parathion is an organophosphate commonly used as an agricultural insecticide, which only becomes toxic - highly toxic - when metabolized in the body to form paraoxon. RRL synthesized paraoxon as an active ingredient because it was "reasonably easy" to make, required a fatal dose of 1mg per kilogram of body weight which was quickly absorbed and, if detected post-mortem, could always be attributed to parathion, and because research into paraoxon offered an ideal cover for establishment of the laboratory in which research would be done on Sarin, Tabun and VX, since the same stringent standards applied for work on the poisons as on the nerve gases. Immelman believed the parathion research could result in a new way of treating organophosphate poisoning through hydrolysis, and when this was achieved, RRL scored a world breakthrough. Every organophosphate Immelman could find was exposed to the process and the only one on which it did not work was Microtox. Paraoxon was added to lip balm, shampoo and roll-on deodorant, RRL not having the facility to place it in aerosol containers. Kobus Niewenhuisen was involved in the toiletries project while Klaus Psotta (his predecessor as head of the chemical department) carried out research on paraoxon mixed with tobacco. Paraoxon - a thin, oily substance in its natural form - was also mixed with alcoholic beverages. Immelman told the court Basson had access to all pathogens and toxins produced by RRL and several of them were delivered to Basson by Immelman. Deliveries that predate the 1989 Sales List and which he can remember are:
|